Literature DB >> 24962484

Use of apixaban for an elderly patient with left atrial thrombus.

Shintaro Dobashi1, Tadashi Fujino1, Takanori Ikeda1.   

Abstract

An 86-year-old man had long-standing persistent atrial fibrillation, but had not received any anticoagulants. Transthoracic echocardiography revealed a large thrombus formation in the left atrium. We hesitated to use the conventional anticoagulant, warfarin, because he was very old and had dementia. We decided to resolve the thrombus at our outpatient clinic. He was started on the novel oral anticoagulant, apixaban, 2.5 mg twice daily, which is a direct factor Xa (FXa) inhibitor. After 11 weeks on that therapy, the thrombus formation had almost resolved. During oral anticoagulant therapy, no serious bleeding complications, systemic embolisms or strokes were noted. To the best of our knowledge, we are the first to report that apixaban (5 mg/day) can possibly resolve a thrombus formation in the left atrium. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24962484      PMCID: PMC4069635          DOI: 10.1136/bcr-2014-203870

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Regression of intracardiac thrombus after embolic stroke.

Authors:  M Yasaka; T Yamaguchi; T Miyashita; T Tsuchiya
Journal:  Stroke       Date:  1990-11       Impact factor: 7.914

Review 2.  Dabigatran and left atrial appendage thrombus.

Authors:  Alejandro Vidal; Gabriel Vanerio
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

3.  Dissolution of the left atrial appendage thrombus with rivaroxaban therapy.

Authors:  Junji Takasugi; Hiroshi Yamagami; Takuya Okata; Kazunori Toyoda; Kazuyuki Nagatsuka
Journal:  Cerebrovasc Dis       Date:  2013-10-30       Impact factor: 2.762

4.  Resolution of giant left atrial appendage thrombus with rivaroxaban.

Authors:  Christoph Hammerstingl; Berndt Pötzsch; Georg Nickenig
Journal:  Thromb Haemost       Date:  2013-01-24       Impact factor: 5.249

5.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

6.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

7.  Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.

Authors:  Rémi Varin; Shahsultan Mirshahi; Pezhman Mirshahi; Christophe Klein; Jovid Jamshedov; Jean Chidiac; Elisabeth Perzborn; Massoud Mirshahi; Claudine Soria; Jeannette Soria
Journal:  Thromb Res       Date:  2013-01-11       Impact factor: 3.944

Review 8.  New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.

Authors:  Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Kurt Huber; Jørgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; João Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Jeffrey I Weitz
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094

9.  Resolution of left atrial appendage thrombus with apixaban.

Authors:  Tohru Kawakami; Hiroko Kobayakawa; Hiroyoshi Ohno; Nobukiyo Tanaka; Hiroki Ishihara
Journal:  Thromb J       Date:  2013-12-20

10.  Dabigatran for left atrial thrombus.

Authors:  Sae Morita; Yoichi Ajiro; Yoshie Uchida; Kazunori Iwade
Journal:  Eur Heart J       Date:  2013-05-22       Impact factor: 29.983

  10 in total
  12 in total

1.  Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series.

Authors:  Keaton S Smetana; Jessie Dunne; Kevin Parrott; George A Davis; Amy C Schmelzer Collier; Mary Covell; Susan Smyth
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

2.  Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.

Authors:  Marion Ferner; Daniel Wachtlin; Torsten Konrad; Oliver Deuster; Thomas Meinertz; Stephan von Bardeleben; Thomas Münzel; Monika Seibert-Grafe; Günter Breithardt; Thomas Rostock
Journal:  Clin Res Cardiol       Date:  2015-06-25       Impact factor: 5.460

Review 3.  Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.

Authors:  Eiman Ghaffarpasand; Maneli D Tehrani; Jolanta Marszalek; Gerald Chi
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

4.  Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution.

Authors:  Michael S Wu; James Gabriels; Mohammad Khan; Nada Shaban; Salvatore A D'Amato; Christopher F Liu; Steven M Markowitz; James E Ip; George Thomas; Parmanand Singh; Bruce B Lerman; Apoor Patel; Jim W Cheung
Journal:  J Interv Card Electrophysiol       Date:  2018-08-04       Impact factor: 1.900

5.  Left atrial thrombus formation and resolution during dabigatran therapy: A Japanese Heart Rhythm Society report.

Authors:  Hideo Mitamura; Takayuki Nagai; Atsuyuki Watanabe; Seiji Takatsuki; Ken Okumura
Journal:  J Arrhythm       Date:  2015-03-04

Review 6.  Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.

Authors:  Fabio Marsico; Milena Cecere; Antonio Parente; Stefania Paolillo; Fabiana de Martino; Santo Dellegrottaglie; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

7.  Left Atrial Appendage Thrombus Resolution with Reduced Dose Apixaban.

Authors:  Beatriz Vaquerizo; Magdi Sami
Journal:  J Atr Fibrillation       Date:  2015-06-30

8.  Right ventricular thrombus formation in a patient with arrhythmogenic right ventricular dysplasia following radiofrequency ablation.

Authors:  Stephan Kemmner; Hasema Lesevic; Tilko Reents; Heribert Schunkert; Christof Burgdorf
Journal:  Clin Case Rep       Date:  2016-04-23

9.  Left atrium mass in a patient with breast cancer: a case report.

Authors:  Yu Sugawara; Ryuji Okamura; Shigeki Taniguchi
Journal:  J Med Case Rep       Date:  2016-10-19

Review 10.  Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis: A case report and literature review.

Authors:  Yuechun Li; Jiafeng Lin; Chen Peng
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.